Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 04.05.2026 2 Ann Surg Oncol 1 Br J Cancer 1 Br J Dermatol 2 Int J Cancer 2 J Am Acad Dermatol 1 J Clin Invest 1 J Invest Dermatol 1 J Surg Oncol 5 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. BROWN M, Lee TS, Li I, Allan C, et al
   ASO Author Reflections: Rethinking Lymphedema Prophylaxis After Groin Dissection for Melanoma.
   Ann Surg Oncol. 2026 Apr 28. doi: 10.1245/s10434-026-19697.
   PubMed        
   
   
2. HERB J, Bassett RL, Torres-Cabala CA, Prieto VG, et al
   Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
   Ann Surg Oncol. 2026 Apr 24. doi: 10.1245/s10434-026-19737.
   PubMed        
   
   

   
   Br J Cancer

3. ESTAY R, Cortes A, Muller B, Tempio F, et al
   Phase I trial of a heat-conditioned tumor lysate vaccine (TRIMELVax) in anti-PD-1 refractory melanoma: safety and immunological aspects (NCT06556004).
   Br J Cancer. 2026 Apr 30. doi: 10.1038/s41416-026-03459.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

4. MIKIVER R, Marjanovic M, Nielsen K, Isaksson K, et al
   Impact of occult metastasis size on mortality in stage IIIA melanoma: A Swedish population-based registry study.
   Br J Dermatol. 2026 Apr 30:ljag171. doi: 10.1093.
   PubMed        
   
   

   
   Int J Cancer

5. GARITAONAINDIA Y, Petersen SK, Guldbrandt LM, Borch TH, et al
   Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.
   Int J Cancer. 2026 Apr 28. doi: 10.1002/ijc.70520.
   PubMed         Abstract available
   
   
6. ZELL T, Kott J, Zimmermann N, Ancker G, et al
   The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.
   Int J Cancer. 2026 Apr 27. doi: 10.1002/ijc.70523.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

7. KIM YH, Jing FZ, Brewer JD, Demer AM, et al
   Response to O'Neill et al.'s "Disparities in melanoma survival in Asian American and Pacific Islander patients: A Surveillance, Epidemiology, and End Results (SEER) program-based analysis".
   J Am Acad Dermatol. 2026 Apr 24:S0190-9622(26)02515.
   PubMed        
   
   
8. KREMER N, Polo-Silveira L, Dana I, Liao V, et al
   Differentiating Head and Neck Small-Diameter Lentigo Maligna and Lentigo Maligna Melanoma (LM/LMM) from Challenging Solar Lentigines (SLs): A Retrospective Study.
   J Am Acad Dermatol. 2026 Apr 24:S0190-9622(26)00620.
   PubMed        
   
   

   
   J Clin Invest

9. XING W, Zhou Y, Haedicke K, Wang C, et al
   Label-free streamlined photoacoustic image guidance facilitates NIR-II photoablation in models of melanoma lung metastases.
   J Clin Invest. 2026;136:e196095.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

10. BOOSTANI M, Siegel AP, Eathara A, Kiss N, et al
    Skin imaging techniques for melanoma detection: A scoping review of modalities, clinical viability, and deployment strategies.
    J Invest Dermatol. 2026 Apr 24:S0022-202X(26)00754.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

11. ADAWI Q, Meiri H, Yoschpe A, Shapira R, et al
    Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study.
    J Surg Oncol. 2026 Apr 29. doi: 10.1002/jso.70282.
    PubMed         Abstract available
    
    

    
    Melanoma Res

12. PERI K, Gupta S, Moshkovich M, Yakubov R, et al
    Prognostic capabilities of circulating tumor DNA in predicting relapse in late-stage melanoma: a scoping review.
    Melanoma Res. 2026;36:236-238.
    PubMed        
    
    
13. ABOELATTA MA, Rezazadeh A, Sener U, Breen WG, et al
    Outcomes and prognostic factors in melanoma patients with leptomeningeal disease: a retrospective cohort study.
    Melanoma Res. 2026;36:203-210.
    PubMed         Abstract available
    
    
14. BERINI CR, Paulus JK, Charles M, Su Z, et al
    Real-world recurrence-free and distant metastasis-free survival in early-stage melanoma: concordance with KEYNOTE-716 trial estimates.
    Melanoma Res. 2026 Apr 29. doi: 10.1097/CMR.0000000000001101.
    PubMed         Abstract available
    
    
15. LU X, Chen M, Fan H, Gao S, et al
    E26 transformation-specific translocation variant 4 participates in melanoma progression and immune evasion by mediating the CD47molecule/signal regulatory protein alpha pathway.
    Melanoma Res. 2026 Apr 27. doi: 10.1097/CMR.0000000000001099.
    PubMed         Abstract available
    
    
16. VINNICOMBE Z, Singh M, Odili J, Soldin M, et al
    The London Melanonychia Assessment Tool for the identification of malignant lesions in patients presenting with melanonychia.
    Melanoma Res. 2026;36:197-202.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum